Healthcare Sector

PTCT

Market Tracker

$68.69
-2.16
(-3.05%)
4:51 am
Next Earnings: (est.) 08/05/23 12:00 am
  • PTCT (Selected)

    PTC Therapeutics, Inc.

PTCT Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PTCT Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PTCT Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PTCT Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PTCT Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PTCT Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/21/2028 CALL $70.00 4,271 +150 +3.64%
05/15/2026 CALL $75.00 2 +1 +100.00%
05/15/2026 CALL $80.00 17 +1 +6.25%
05/15/2026 CALL $85.00 3 +1 +50.00%
05/15/2026 PUT $60.00 3 +1 +50.00%
04/17/2026 CALL $35.00 0 0
01/21/2028 PUT $90.00 0 0
01/21/2028 PUT $95.00 0 0
01/21/2028 PUT $100.00 3 0
01/21/2028 PUT $105.00 0 0
01/21/2028 PUT $110.00 0 0
01/21/2028 PUT $115.00 0 0

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PTCT Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.96% 2.18M 87.61M
Vanguard Small-Cap Index Fund 2.51% 1.85M 74.35M
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 2.45% 1.81M 72.62M
Fidelity Select Portfolios - Biotechnology 2.20% 1.62M 65.1M
iShares Russell 2000 ETF 2.09% 1.55M 62.06M
Hartford Mid Cap Fund 1.90% 1.4M 56.17M
Vanguard Specialized-Health Care Fund 1.67% 1.24M 49.62M
Delaware Group Equity Fds V-Small Cap Core Fund 1.48% 1.1M 43.98M
Vanguard Small-Cap Growth Index Fund 1.45% 1.07M 42.97M
Vanguard Extended Market Index Fund 1.32% 976.77k 39.22M

PTCT News

  • What's Going On With Royalty Pharma Stock Wednesday?

    12/31 11:47 am

    Benzinga

    Read more
  • Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones

    12/29 05:40 pm

    Benzinga

    Read more
  • Here's Why Shares in PTC Therapeutics Soared This Week

    09/05 08:35 am

    The Motley Fool

    Read more
  • Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance

    07/17 01:00 am

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    06/02 01:55 pm

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

    06/02 01:52 pm

    GlobeNewswire Inc.

    Read more
  • Evolving Landscape of Mitochondrial Disease Market: Key Insights of Latest Published Report—Leigh Syndrome, Leber’s Hereditary Optic Neuropathy, MELAS Syndrome, and Thymidine Kinase 2 Deficiency | DelveInsight

    05/26 01:00 pm

    GlobeNewswire Inc.

    Read more
  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

    08/03 03:41 pm

    GlobeNewswire Inc.

    Read more
  • PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - GlobeNewswire

    07/09 02:01 pm

    GlobeNewswire Inc.

    Read more
  • PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug

    07/01 08:00 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?

    06/24 04:44 am

    Zacks Investment Research

    Read more
  • The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics

    05/24 09:38 am

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

    05/23 12:46 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

    05/21 12:26 pm

    Zacks Investment Research

    Read more
  • Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics

    04/25 08:00 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    04/18 10:01 am

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More

    03/21 10:01 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Up on Positive Regulatory Updates

    03/20 02:00 pm

    Zacks Investment Research

    Read more
  • Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday

    03/01 12:18 pm

    Benzinga

    Read more
  • Here's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings

    02/29 07:00 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates

    02/29 06:20 pm

    Zacks Investment Research

    Read more
  • Wall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings

    02/26 10:16 am

    Zacks Investment Research

    Read more
  • Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know

    02/14 11:00 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth

    02/13 11:00 am

    Zacks Investment Research

    Read more
  • 1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?

    02/11 02:45 am

    The Motley Fool

    Read more
  • Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?

    01/05 04:09 am

    Zacks Investment Research

    Read more
  • Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU

    12/18 10:57 am

    Zacks Investment Research

    Read more
  • Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up

    12/08 06:37 am

    Zacks Investment Research

    Read more
  • Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug

    11/23 12:47 pm

    Zacks Investment Research

    Read more
  • Analyst Expectations for PTC Therapeutics's Future

    11/20 11:00 am

    Benzinga

    Read more
  • Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND

    11/16 09:29 am

    Zacks Investment Research

    Read more
  • Pinterest Primed for Rich Ad Spend; Adobe a Powerhouse: Street Calls of the Week

    10/29 09:46 am

    Investing.com

    Read more
  • Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday

    10/27 08:06 am

    Benzinga

    Read more
  • The Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical

    10/27 07:15 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

    10/26 07:30 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Reports Q3 Loss, Lags Revenue Estimates

    10/26 05:30 pm

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: BMY's Q3 Results, PTCT Up on Deal, BEAM's Restructuring News

    10/26 11:28 am

    Zacks Investment Research

    Read more
  • Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    10/24 10:00 am

    Zacks Investment Research

    Read more
  • Why PTC Therapeutics Soared 15% Higher Today

    10/19 07:02 pm

    The Motley Fool

    Read more
  • Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings

    10/19 02:37 pm

    Benzinga

    Read more
  • Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    10/19 01:52 pm

    Benzinga

    Read more
  • PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    10/19 10:01 am

    Zacks Investment Research

    Read more
  • AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday

    10/19 09:56 am

    Benzinga

    Read more
  • PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion

    10/19 09:18 am

    MarketWatch

    Read more
  • PTC Therapeutics (PTCT) Moves 5.3% Higher: Will This Strength Last?

    10/11 08:07 am

    Zacks Investment Research

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023

    10/06 11:00 am

    Benzinga

    Read more
  • PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024

    09/29 11:18 am

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down

    09/21 10:43 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains?

    09/20 04:00 am

    Zacks Investment Research

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: